ExploreWatchlistsPricing
  1. JP-listed companies
  2. Alfresa Holdings Corporation
  3. Financials
  4. Revenue growth (%)

Alfresa Holdings Corporation (2784)

Market cap
¥417.9B
P/E ratio
18.8x
Alfresa Holdings distributes prescription drugs, medical devices, and healthcare products to serve Japan's medical industry through specialized subsidiaries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Mar 31, 20264.8+34.54%
Mar 31, 20253.6-40.37%
Mar 31, 20246+40.98%
Mar 31, 20234.3-737.31%
Mar 31, 2022-0.7-81.02%
Mar 31, 2021-3.5-260.45%
Mar 31, 20202.2+52.78%
Mar 31, 20191.4-28.00%
Mar 31, 20182-310.53%
Mar 31, 2017-0.9-114.82%
Mar 31, 20166.4-292.49%
Mar 31, 2015-3.3-167.96%
Mar 31, 20144.9+110.30%
Mar 31, 20132.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat